How I treat monoclonal gammopathy of renal significance (MGRS).

Abstract:

:Recently, the term monoclonal gammopathy of renal significance (MGRS) was introduced to distinguish monoclonal gammopathies that result in the development of kidney disease from those that are benign. By definition, patients with MGRS have B-cell clones that do not meet the definition of multiple myeloma or lymphoma. Nevertheless, these clones produce monoclonal proteins that are capable of injuring the kidney resulting in permanent damage. Except for immunoglobulin light chain amyloidosis with heart involvement in which death can be rapid, treatment of MGRS is often indicated more to preserve kidney function and prevent recurrence after kidney transplantation rather than the prolongation of life. Clinical trials are rare for MGRS-related kidney diseases, except in immunoglobulin light chain amyloidosis. Treatment recommendations are therefore based on the clinical data obtained from treatment of the clonal disorder in its malignant state. The establishment of these treatment recommendations is important until data can be obtained by clinical trials of MGRS-related kidney diseases.

journal_name

Blood

journal_title

Blood

authors

Fermand JP,Bridoux F,Kyle RA,Kastritis E,Weiss BM,Cook MA,Drayson MT,Dispenzieri A,Leung N,International Kidney and Monoclonal Gammopathy Research Group.

doi

10.1182/blood-2013-05-495929

subject

Has Abstract

pub_date

2013-11-21 00:00:00

pages

3583-90

issue

22

eissn

0006-4971

issn

1528-0020

pii

blood-2013-05-495929

journal_volume

122

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

    abstract::Twenty-two molecular diagnostic laboratories from 14 countries participated in a consortium study to estimate the impact of Factor VIII gene inversions in severe hemophilia A. A total of 2,093 patients with severe hemophilia A were studied; of those, 740 (35%) had a type 1 (distal) factor VIII inversion, and 140 (7%) ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Antonarakis SE,Rossiter JP,Young M,Horst J,de Moerloose P,Sommer SS,Ketterling RP,Kazazian HH Jr,Négrier C,Vinciguerra C,Gitschier J,Goossens M,Girodon E,Ghanem N,Plassa F,Lavergne JM,Vidaud M,Costa JM,Laurian Y,Lin

    更新日期:1995-09-15 00:00:00

  • Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development.

    abstract::Mice deficient in c-fms-like tyrosine kinase 3 (FLT3) signaling have reductions in early multipotent and lymphoid progenitors, whereas no evident myeloid phenotype has been reported. However, activating mutations of Flt3 are among the most common genetic events in acute myeloid leukemia and mice harboring internal tan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-12-258756

    authors: Böiers C,Buza-Vidas N,Jensen CT,Pronk CJ,Kharazi S,Wittmann L,Sitnicka E,Hultquist A,Jacobsen SE

    更新日期:2010-06-17 00:00:00

  • Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.

    abstract::The proteolytic cleavage and subsequent inactivation of recombinant human factor VIII (rhFVIII) and human factor VIIIa (rhFVIIIa) by recombinant human activated protein C (rAPC) was analyzed in the presence and absence of human protein S and human factor V (FV). Membrane-bound rhFVIIIa spontaneously looses most of its...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lu D,Kalafatis M,Mann KG,Long GL

    更新日期:1996-06-01 00:00:00

  • The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.

    abstract::A deficiency of adenosine deaminase, an enzyme important in purine nucleoside catabolism, is associated with a severe combined immunodeficiency disease in children. Inhibition of this enzyme in vitro and in vivo results in an impairment in lymphoblast proliferation. We have investigated the pharmacologic inhibition of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grever MR,Siaw MF,Jacob WF,Neidhart JA,Miser JS,Coleman MS,Hutton JJ,Balcerzak SP

    更新日期:1981-03-01 00:00:00

  • Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium.

    abstract::The chemokines platelet factor 4 (PF4) and RANTES (regulated on activation normal T cell expressed and secreted) are secreted by activated platelets and influence multiple cell types and biologic processes. For instance, PF4 inhibits progenitor cell proliferation and angiogenesis, while platelet-derived RANTES is invo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2475

    authors: von Hundelshausen P,Koenen RR,Sack M,Mause SF,Adriaens W,Proudfoot AE,Hackeng TM,Weber C

    更新日期:2005-02-01 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00

  • A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes.

    abstract::The regulator of G-protein signaling (RGS) negatively regulates the alpha subunit of G proteins by accelerating their intrinsic guanosine triphosphatase (GTPase) activity. Here are reported the isolation and characterization of a novel mouse RGS, termed RGS18, which is a new member of RGS subfamily B. Northern blot an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.3051

    authors: Nagata Y,Oda M,Nakata H,Shozaki Y,Kozasa T,Todokoro K

    更新日期:2001-05-15 00:00:00

  • Nonsteroidal anti-inflammatory drugs inhibit a Fyn-dependent pathway coupled to Rac and stress kinase activation in TCR signaling.

    abstract::In addition to their anti-inflammatory properties, nonsteroidal anti-inflammatory drugs (NSAIDs) harbor immunosuppressive activities related to their capacity both to inhibit cyclooxygenases (COXs) and to act as peroxisome proliferator-activated receptor (PPAR) ligands. We have previously shown that the stress-activat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-04-1299

    authors: Paccani SR,Patrussi L,Ulivieri C,Masferrer JL,D'Elios MM,Baldari CT

    更新日期:2005-03-01 00:00:00

  • Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.

    abstract::Human blood contains 2 populations of dendritic cells (DCs): plasmacytoid and myeloid (mDC). mDCs are subdivided into 3 subsets using the surface markers CD16, CD1c, and BDCA-3. Their role as pathogen sentinels and adjuvant targets was tested by phenotypic and functional analysis. We show that mDC subsets are immature...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-038422

    authors: Piccioli D,Tavarini S,Borgogni E,Steri V,Nuti S,Sammicheli C,Bardelli M,Montagna D,Locatelli F,Wack A

    更新日期:2007-06-15 00:00:00

  • ALK+ lymphoma: clinico-pathological findings and outcome.

    abstract::A distinct pathologic entity (ALK+ lymphoma) that is characterized by expression of the anaplastic lymphoma kinase (ALK) protein has recently emerged within the heterogeneous group of CD30(+) anaplastic large-cell lymphomas. Information on clinical findings and treatment outcome of ALK+ lymphoma is still limited, and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Falini B,Pileri S,Zinzani PL,Carbone A,Zagonel V,Wolf-Peeters C,Verhoef G,Menestrina F,Todeschini G,Paulli M,Lazzarino M,Giardini R,Aiello A,Foss HD,Araujo I,Fizzotti M,Pelicci PG,Flenghi L,Martelli MF,Santucci A

    更新日期:1999-04-15 00:00:00

  • Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

    abstract::Serum from 398 myeloma patients at diagnosis and serial samples from 29 patients were analysed for hepatocyte growth factor (HGF). HGF was elevated at diagnosis in 43% of myeloma patients compared with healthy controls (median 1.00 ng/mL and 0.44 ng/mL, respectively; P < .00001). In the group with elevated HGF levels ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Seidel C,Børset M,Turesson I,Abildgaard N,Sundan A,Waage A

    更新日期:1998-02-01 00:00:00

  • Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

    abstract::Allogeneic hematopoietic stem cell transplantation (HSCT) is widely used to treat hematopoietic cell disorders but is often complicated by graft-versus-host disease (GVHD), which causes severe epithelial damage. Here we have investigated longitudinally the effects of induction chemotherapy, conditioning radiochemother...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2013-11-536888

    authors: Munneke JM,Björklund AT,Mjösberg JM,Garming-Legert K,Bernink JH,Blom B,Huisman C,van Oers MH,Spits H,Malmberg KJ,Hazenberg MD

    更新日期:2014-07-31 00:00:00

  • Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells.

    abstract::Granulocyte colony-stimulating factor (G-CSF) may affect T-cell homeostasis by multiple mechanisms, inducing polarization of cytokine secretion, inhibition of T-cell proliferation, and enhancement of T-cell apoptosis. We analyzed the production of interleukin-10 (IL-10) and transforming growth factor-beta1 (TGF-beta1)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0291

    authors: Rutella S,Pierelli L,Bonanno G,Sica S,Ameglio F,Capoluongo E,Mariotti A,Scambia G,d'Onofrio G,Leone G

    更新日期:2002-10-01 00:00:00

  • Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

    abstract::The effect of recombinant factor VIII (rFVIII) brand on inhibitor development was investigated in all 407 severe hemophilia A previously untreated patients born in the United Kingdom (UK) between 1 January 2000 and 31 December 2011. Eighty-eight (22%) had been in the RODIN study. Information was extracted from the Nat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-580498

    authors: Collins PW,Palmer BP,Chalmers EA,Hart DP,Liesner R,Rangarajan S,Talks K,Williams M,Hay CR,UK Haemophilia Centre Doctors’ Organization.

    更新日期:2014-11-27 00:00:00

  • Striking inverse correlation between IgG anti-F(ab')2 and autoantibody production in patients with cold agglutination.

    abstract::Previous experiments showed that the physiologic IgG anti-F(ab')2 antibody suppresses the response of human autoreactive B cells. In the present study, we analyzed the IgG anti-F(ab')2 antibody in 293 patients with cold agglutination (CA). Their average IgG anti-F(ab')2 titer was not much different (211 +/- 8.3) from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Terness P,Kirschfink M,Navolan D,Dufter C,Kohl I,Opelz G,Roelcke D

    更新日期:1995-01-15 00:00:00

  • B19 parvovirus replicates in circulating cells of acutely infected patients.

    abstract::B19 parvovirus is the etiologic agent of fifth disease and transient aplastic crisis. In natural infections, B19 antigen and DNA have been detected in sera early in the course of aplastic crisis and only rarely in fifth disease. We have found B19 DNA in circulating cells of infected patients by DNA dot blot with a vir...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kurtzman GJ,Gascon P,Caras M,Cohen B,Young NS

    更新日期:1988-05-01 00:00:00

  • Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces.

    abstract::Fibronectin (FN) plays a role in several adhesion mediated functions including the interaction of platelets with subendothelium. We investigated the role of plasma FN in platelet adhesion and platelet thrombus formation under flow conditions. We used two different perfusion models: the annular chamber with alpha-chymo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bastida E,Escolar G,Ordinas A,Sixma JJ

    更新日期:1987-11-01 00:00:00

  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

    abstract::Most anticancer chemotherapies are immunosuppressive and induce nonimmunogenic tumor cell death. Bortezomib, a specific inhibitor of 26S proteasome, has shown clinical activity in several human tumors, including myeloma. Here we show that the uptake of human myeloma cells by dendritic cells (DCs) after tumor cell deat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-054221

    authors: Spisek R,Charalambous A,Mazumder A,Vesole DH,Jagannath S,Dhodapkar MV

    更新日期:2007-06-01 00:00:00

  • The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

    abstract::Cytogenetics is considered one of the most valuable prognostic determinants in acute myeloid leukemia (AML). However, many studies on which this assertion is based were limited by relatively small sample sizes or varying treatment approach, leading to conflicting data regarding the prognostic implications of specific ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Grimwade D,Walker H,Oliver F,Wheatley K,Harrison C,Harrison G,Rees J,Hann I,Stevens R,Burnett A,Goldstone A

    更新日期:1998-10-01 00:00:00

  • Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.

    abstract::This study examined the prognostic value of circulating peripheral blood plasma cells (PBPCs) in patients with primary systemic amyloidosis (AL). A sensitive slide-based immunofluorescence technique was used to assess 147 patients for circulating PBPCs. Circulating monoclonal plasma cells were quantified as a percenta...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1698

    authors: Pardanani A,Witzig TE,Schroeder G,McElroy EA,Fonseca R,Dispenzieri A,Lacy MQ,Lust JA,Kyle RA,Greipp PR,Gertz MA,Rajkumar SV

    更新日期:2003-02-01 00:00:00

  • How I treat childhood CML.

    abstract::Chronic myeloid leukemia (CML) is composed of 3% of pediatric leukemias, making evidence-based recommendations difficult. Imatinib has revolutionized the treatment for adult CML by eliminating allogeneic stem cell transplantation for almost all patients in chronic phase. Shown effective in pediatric CML, imatinib and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-380774

    authors: Andolina JR,Neudorf SM,Corey SJ

    更新日期:2012-02-23 00:00:00

  • Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops.

    abstract::The biologic effects of endothelin-1 (ET-1) are not limited to its potent vasoconstricting activity. The endothelin receptors, ETA and ETB, have differential tissue and functional distributions. Here we showed that dendritic cells (DCs), the major antigen-presenting cells in the adaptive limb of the immune system, pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3559

    authors: Guruli G,Pflug BR,Pecher S,Makarenkova V,Shurin MR,Nelson JB

    更新日期:2004-10-01 00:00:00

  • Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

    abstract::Chimeric antigen receptor (CAR) T cells have emerged as a novel form of treatment of patients with B-cell malignancies. In particular, anti-CD19 CAR T-cell therapy has effected impressive clinical responses in B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. However, not all patients respond, and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-842708

    authors: Scarfò I,Ormhøj M,Frigault MJ,Castano AP,Lorrey S,Bouffard AA,van Scoyk A,Rodig SJ,Shay AJ,Aster JC,Preffer FI,Weinstock DM,Maus MV

    更新日期:2018-10-04 00:00:00

  • BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks.

    abstract::The oncogenic BCR/ABL tyrosine kinase induces constitutive DNA damage in Philadelphia chromosome (Ph)-positive leukemia cells. We find that BCR/ABL-induced reactive oxygen species (ROSs) cause chronic oxidative DNA damage resulting in double-strand breaks (DSBs) in S and G(2)/M cell cycle phases. These lesions are rep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-1941

    authors: Nowicki MO,Falinski R,Koptyra M,Slupianek A,Stoklosa T,Gloc E,Nieborowska-Skorska M,Blasiak J,Skorski T

    更新日期:2004-12-01 00:00:00

  • A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.

    abstract::One hundred thirty-eight patients with hairy cell leukemia were randomized to receive either a dose of 2.0 megaunits (MU)/m2 or a 10-fold lower dose of 0.2 MU/m2 of a highly purified natural alpha-interferon, administered daily for 28 days followed by a three times a week schedule. Ninety-seven of these patients had p...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Smalley RV,Anderson SA,Tuttle RL,Connors J,Thurmond LM,Huang A,Castle K,Magers C,Whisnant JK

    更新日期:1991-12-15 00:00:00

  • Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.

    abstract::Several transgenic murine models for sickle cell anemia have been developed that closely reproduce the biochemical and physiological disorders in the human disease. A comprehensive characterization is described of hematologic parameters of mature red blood cells, reticulocytes, and red cell precursors in the bone marr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.5.1577

    authors: de Jong K,Emerson RK,Butler J,Bastacky J,Mohandas N,Kuypers FA

    更新日期:2001-09-01 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • Separation of human plasma factor IX from HTLV-I or HIV by immunoaffinity chromatography using conformation-specific antibodies.

    abstract::Immunoaffinity chromatography using conformation-specific antibodies yields pure factor IX from human plasma in a single rapid, facile purification step. We evaluated this technique to determine whether factor IX can be separated from human T cell leukemia virus-I (HTLV-I) and human immunodeficiency virus (HIV) in pla...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Limentani SA,Furie BC,Poiesz BJ,Montagna R,Wells K,Furie B

    更新日期:1987-11-01 00:00:00

  • Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

    abstract::This phase 2 study evaluated whether substituting bortezomib for vincristine in frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy could improve efficacy in non-germinal center B-cell-like diffuse large B-cell lymphoma (non-GCB DLBCL), centrally confirmed by immunohist...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-03-632430

    authors: Offner F,Samoilova O,Osmanov E,Eom HS,Topp MS,Raposo J,Pavlov V,Ricci D,Chaturvedi S,Zhu E,van de Velde H,Enny C,Rizo A,Ferhanoglu B

    更新日期:2015-10-15 00:00:00